These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 2825733)

  • 1. Male breast carcinoma. I. A study of the total material reported to the Swedish Cancer Registry 1958-1967 with respect to clinical and histopathologic parameters.
    Hultborn R; Friberg S; Hultborn KA
    Acta Oncol; 1987; 26(4):241-56. PubMed ID: 2825733
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in incidence of in situ and invasive breast cancer by histology type following mammography screening.
    Luke C; Priest K; Roder D
    Asian Pac J Cancer Prev; 2006; 7(1):69-74. PubMed ID: 16629519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in epidemiology, clinical and histopathological characteristics of breast cancer in Iran: results of a 17 year study.
    Afsharfard A; Mozaffar M; Orang E; Tahmasbpour E
    Asian Pac J Cancer Prev; 2013; 14(11):6905-11. PubMed ID: 24377624
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Breast cancer in the catchment area of the Graz Institute of Pathology. Evaluation of morphologic parameters based on 1,510 cases].
    Hauser H; Beham A; Steindorfer P; Smola MG; Fruhwirth H; Klimpfinger M
    Wien Klin Wochenschr; 1992; 104(23):717-20. PubMed ID: 1335634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The distribution of ductal carcinoma in situ (DCIS) grade in 4232 women and its impact on overdiagnosis in breast cancer screening.
    van Luijt PA; Heijnsdijk EA; Fracheboud J; Overbeek LI; Broeders MJ; Wesseling J; den Heeten GJ; de Koning HJ
    Breast Cancer Res; 2016 May; 18(1):47. PubMed ID: 27160733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of invasive breast carcinoma among women diagnosed with ductal carcinoma in situ and lobular carcinoma in situ, 1988-2001.
    Li CI; Malone KE; Saltzman BS; Daling JR
    Cancer; 2006 May; 106(10):2104-12. PubMed ID: 16604564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ductal carcinoma in situ of breast: detection and treatment pattern in Hong Kong.
    Yau TK; Chan A; Cheung PS
    Hong Kong Med J; 2017 Feb; 23(1):19-27. PubMed ID: 27779099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Histopathological features of breast cancer in Al-Madinah region of Saudi Arabia.
    Albasri A; Hussainy AS; Sundkji I; Alhujaily A
    Saudi Med J; 2014 Dec; 35(12):1489-93. PubMed ID: 25491214
    [TBL] [Abstract][Full Text] [Related]  

  • 9. First epidemiological analysis of breast cancer incidence and tumor characteristics after implementation of population-based digital mammography screening.
    Weigel S; Batzler WU; Decker T; Hense HW; Heindel W
    Rofo; 2009 Dec; 181(12):1144-50. PubMed ID: 19859859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incidence and clinical features of breast cancer in the Auckland region.
    Newman PD; Mason BH; Holdaway IM; Kay RG; Arthur JF; Hitchcock GC
    N Z Med J; 1992 Apr; 105(931):117-20. PubMed ID: 1313956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast Tumor Prognostic Characteristics and Biennial vs Annual Mammography, Age, and Menopausal Status.
    Miglioretti DL; Zhu W; Kerlikowske K; Sprague BL; Onega T; Buist DS; Henderson LM; Smith RA;
    JAMA Oncol; 2015 Nov; 1(8):1069-77. PubMed ID: 26501844
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective quantification of background incidence and stage distribution of breast cancer for the mammography screening pilot project in Wiesbaden, Germany.
    Schott G; Reichel M; Junkermann H; Becker N
    J Cancer Res Clin Oncol; 2008 Jan; 134(1):29-35. PubMed ID: 17602243
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of subsequent invasive breast cancer after breast carcinoma in situ.
    Wärnberg F; Yuen J; Holmberg L
    Lancet; 2000 Feb; 355(9205):724-5. PubMed ID: 10703809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of age distribution patterns for different histopathologic types of breast carcinoma.
    Anderson WF; Pfeiffer RM; Dores GM; Sherman ME
    Cancer Epidemiol Biomarkers Prev; 2006 Oct; 15(10):1899-905. PubMed ID: 17035397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathologic findings in nonpalpable invasive breast cancer.
    McKinney CD; Frierson HF; Fechner RE; Wilhelm MC; Edge SB
    Am J Surg Pathol; 1992 Jan; 16(1):33-6. PubMed ID: 1309412
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001.
    Li CI; Daling JR; Malone KE
    Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):1008-11. PubMed ID: 15824180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breast screening and breast cancer survival in Aboriginal and Torres Strait Islander women of Australia.
    Roder D; Webster F; Zorbas H; Sinclair S
    Asian Pac J Cancer Prev; 2012; 13(1):147-55. PubMed ID: 22502658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Primary systemic therapy in breast cancer patients (2007-2010)].
    Zapf I; Tizedes G; Pavlovics G; Kovács G; Kálmán E; Szalai G; Kövér E; Farkas R; Horváth OP
    Magy Seb; 2011 Oct; 64(5):223-8. PubMed ID: 21997525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cancerous residue in breast-conserving surgery.
    Morimoto T; Okazaki K; Komaki K; Sasa M; Mori T; Tsuzuki H; Kamamura Y; Miki H; Monden Y
    J Surg Oncol; 1993 Feb; 52(2):71-6. PubMed ID: 8385722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of age-specific incidence rate patterns for different histopathologic types of breast carcinoma.
    Anderson WF; Chu KC; Chang S; Sherman ME
    Cancer Epidemiol Biomarkers Prev; 2004 Jul; 13(7):1128-35. PubMed ID: 15247123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.